December 10, 2025 a 12:46 pm
CVS: Dividend Analysis - CVS Health Corporation
CVS Health Corporation, a notable player in the healthcare sector, offers a respectable dividend yield exceeding 3%. With a steadfast history of 41 years of dividend payments and only one suspension back in 1997, the company's commitment to shareholder returns is evident. However, the high EPS payout ratio raises concerns about the sustainability of its dividends in the long term.
📊 Overview
| Metric | Details |
|---|---|
| Sector | Healthcare |
| Dividend yield | 3.28% |
| Current dividend per share | 2.68 USD |
| Dividend history | 41 years |
| Last cut or suspension | 1997 |
📈 Dividend History
The dividend history indicates consistent payments to shareholders, enhancing investor confidence and showcasing stability in the company's earnings. The ability to maintain a dividend payout through economic cycles underscores CVS's financial resilience and shareholder focus.
| Year | Dividend per Share (USD) |
|---|---|
| 2025 | 2.66 |
| 2024 | 2.66 |
| 2023 | 2.42 |
| 2022 | 2.20 |
| 2021 | 2.00 |
📈 Dividend Growth
Dividend growth has been modest, with considerable fluctuations over the past 5 years. A higher rate of dividend increase is usually preferred by investors, as it signals confidence in the company's future income potential and management's commitment to reward shareholders.
| Time | Growth |
|---|---|
| 3 years | 9.97% |
| 5 years | 5.87% |
The average dividend growth is 5.87% over 5 years. This shows moderate but steady dividend growth, allowing for some optimism among long-term investors.
📊 Payout Ratio
The payout ratio is vital in determining a company's dividend sustainability. CVS's EPS payout ratio is exceptionally high, which could indicate potential risks. Conversely, the FCF-based payout ratio presents a more balanced view.
| Key figure | Ratio |
|---|---|
| EPS-based | 724.90% |
| Free cash flow-based | 54.04% |
An EPS-based ratio of 724.90% is concerning and suggests dividends might not be covered by net income. However, the FCF-coverage of 54.04% offers more comfort, implying dividends are better supported by actual cash flow.
📊 Cashflow & Capital Efficiency
Cash flow stability and capital efficiency are crucial indicators of a company's operational health and its ability to support dividend payments.
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Free Cash Flow Yield | 11.19% | 10.25% | 11.00% |
| Earnings Yield | 8.16% | 8.22% | 3.53% |
| CAPEX to Operating Cash Flow | 30.94% | 22.58% | 16.86% |
| Stock-based Compensation to Revenue | 0.15% | 0.16% | 0.14% |
| Free Cash Flow / Operating Cash Flow Ratio | 69.46% | 77.42% | 83.14% |
The figures suggest robust free cash flow with efficient capital allocation, providing adequate support for ongoing dividend payments and potential growth.
📊 Balance Sheet & Leverage Analysis
A comprehensive analysis of the balance sheet indicates CVS's leverage position and its capacity to manage and service its debt efficiently.
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Debt-to-Equity | 1.10 | 1.04 | 0.99 |
| Debt-to-Assets | 32.75% | 31.79% | 30.99% |
| Debt-to-Capital | 52.32% | 50.94% | 49.74% |
| Net Debt to EBITDA | 5.43 | 3.91 | 4.68 |
| Current Ratio | 0.81 | 0.86 | 0.95 |
| Quick Ratio | 0.60 | 0.63 | 0.67 |
| Financial Leverage | 3.35 | 3.27 | 3.19 |
While debt levels have decreased slightly, the current ratios suggest tight liquidity, indicating an area to watch for future financial flexibility.
📊 Fundamental Strength & Profitability
Fundamental strength and profitability are key indicators of the company's ability to generate sustainable profits and reinvest in growth opportunities.
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Return on Equity | 6.11% | 10.91% | 6.03% |
| Return on Assets | 1.82% | 3.34% | 1.89% |
| Margins: Net | 1.24% | 2.33% | 1.34% |
| Margins: EBIT | 2.44% | 3.87% | 2.52% |
| Margins: EBITDA | 3.67% | 5.09% | 3.83% |
| Margins: Gross | 13.79% | 15.21% | 16.90% |
| Research & Development to Revenue | 0.00% | 0.00% | 0.00% |
Profit margins display a competent standing, with gross margins trending downwards while other margins show moderate improvement, reflecting mixed profitability characteristics.
📉 Price Development
🗣️ Dividend Scoring System
| Category | Score | Visual |
|---|---|---|
| Dividend yield | 4 | |
| Dividend Stability | 4 | |
| Dividend growth | 3 | |
| Payout ratio | 2 | |
| Financial stability | 3 | |
| Dividend continuity | 5 | |
| Cashflow Coverage | 4 | |
| Balance Sheet Quality | 2 |
Overall Score: 27/40
✅ Rating
In summary, CVS Health Corporation provides a solid dividend yield with a history of consistent payouts, underpinned by robust cash flow coverage. However, potential risks include a very high EPS payout ratio and limited short-term liquidity. Investors seeking steady income should consider these factors for long-term commitments while remaining vigilant of underlying financial challenges.